5 Surgical Robots to Look Out for in 2019

Surgical robots are evolving, with newer systems incorporating tele-operation, virtual reality training, and more procedures. Here are five to watch.

Just as manufacturers rely on robots to reduce human errors and maintain product quality, so too are surgical robots alleviating fatigue while aiding procedures requiring great precision.

The high cost of surgical robots has been a barrier to adoption, but more hospitals are deciding that they’re worth the investment. The equipment can help surgeons perform minimally invasive operations, from which patients can recover more quickly and easily than traditional procedures.

The global market for surgical robots will experience a compound annual growth rate of 10.4%, from $3.9 billion in 2018 to $6.5 billion by 2023, according to Markets and Markets.

In 2009, Penn State Milton S. Hershey Medical Center began establishing best practices for medical centers using surgical robots. The Journal of the Society of Laparoendoscopic Surgeons noted that the facility initially used robots for only a small assortment of procedures. However, the diversity of uses has increased over the years, with the most growth in gynecology and urology.

While the medical center has used Intuitive Surgical’s da Vinci brand of robots, it has expanded its use of automation to better serve patients.

Many people struggle with the finances for surgery, and some travel to specialized facilities to receive the best available care. Therefore, the priority that the Penn State Milton S. Hershey Medical Center is putting on automation could be an example of how hospitals can gain competitive advantage with surgical robots.

The da Vinci surgical system is a market leader, but other options are emerging, including models for specific procedures. Since some key da Vinci patents recently expired, other companies could seize market share.

By Kayla Matthews | Robotics Business Review

Image Credit: CMR Surgical


About Peter Coffaro 472 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 25 years of progressive management success within the medical device industry. Recognized by the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager, Distributor, and Vice President. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy, and Stryker. He is also the founder of OrthoFeed: a popular blog that covers digital orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing, and professional education. Peter holds a B.S. degree in Biology and Chemistry from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.